日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease.

抑制肌醇激酶 B 可控制急性和慢性移植物抗宿主病

Thangavelu Govindarajan, Du Jing, Paz Katelyn G, Loschi Michael, Zaiken Michael C, Flynn Ryan, Taylor Patricia A, Kirchmeier Andrew Kemal, Panoskaltsis-Mortari Angela, Luznik Leo, MacDonald Kelli P, Hill Geoffrey R, Maillard Ivan, Munn David H, Serody Jonathan S, Murphy William J, Miklos David, Cutler Corey S, Koreth John, Antin Joseph H, Soiffer Robert J, Ritz Jerome, Dahlberg Carol, Miller Andrew T, Blazar Bruce R

Inhibition of the Inositol Kinase Itpkb Augments Calcium Signaling in Lymphocytes and Reveals a Novel Strategy to Treat Autoimmune Disease.

抑制肌醇激酶Itpkb可增强淋巴细胞中的钙信号传导,并揭示治疗自身免疫性疾病的新策略

Miller Andrew T, Dahlberg Carol, Sandberg Mark L, Wen Ben G, Beisner Daniel R, Hoerter John A H, Parker Albert, Schmedt Christian, Stinson Monique, Avis Jacqueline, Cienfuegos Cynthia, McPate Mark, Tranter Pamela, Gosling Martin, Groot-Kormelink Paul J, Dawson Janet, Pan Shifeng, Tian Shin-Shay, Seidel H Martin, Cooke Michael P

The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chain

膜内蛋白酶Sppl2a通过切割不变链,对B细胞和树突状细胞的发育和存活至关重要。

Beisner, Daniel R; Langerak, Petra; Parker, Albert E; Dahlberg, Carol; Otero, Francella J; Sutton, Sue E; Poirot, Laurent; Barnes, Whitney; Young, Michael A; Niessen, Sherry; Wiltshire, Tim; Bodendorf, Ursula; Martoglio, Bruno; Cravatt, Benjamin; Cooke, Michael P